Peptide-primarily based vectors have received attention for their specificity in binding to receptors overexpressed in breast cancer cells, possibly beating challenges linked to minimal internalization. Co-formulation with other permeation enhancers, enzyme inhibitors, and hydrogels have also been used to enable the oral administration of other peptide medicines, including octreotide and https://oliverl865qtu6.mappywiki.com/user